secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001193125-25-072340
Event type: leadership
Sentiment:  negative
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chief Medical Officer Eyal Attar resigns effective April 18, 2025
-----------------------------------------------------------------

- Eyal C. Attar, M.D., resigned as Chief Medical Officer of Vor Biopharma, effective April 18, 2025.
- Resignation is to pursue a new opportunity; no successor named yet.
- Company expects to enter into a consulting agreement for transition services.
- Dr. Attar's departure may impact ongoing clinical development activities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525072340/0001193125-25-072340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525072340/d932261d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-072340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer